Skip to content

Janna R. Cohen-Lehman, D.O.

NPI 1093956989ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Bayside, NY

Internal Medicine, Endocrinology, Diabetes & Metabolism (D.O.) in Bayside, New York, trained at New York College of Osteo Medicine of New York Institute of Technology (class of 2004). Their prescriptions cost Medicare Part D more than their services did: $1,366,192 for 3,908 claims, against $272,177 paid for services in 2024. Novo Nordisk Inc was the largest of 18 companies reporting payments in 2025, $1,444 in all, mostly food and beverage.

Overview

NPI1093956989
StatusActive
Entity typeIndividual
CredentialD.O.
Sole proprietorNo
NPI issuedMar 23, 2009
Last updated in NPPESMar 23, 2009

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NY)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients494
Services billed10,429 across 58 procedure codes
Paid by Medicare$272,177

Part D prescriptions in 2024

Prescriptions (claims)3,908 · 10,146 30-day fills
Patients500
Total drug cost$1,366,192
Generic share62% of claims

Medicare sources and data years

Education and affiliations

Medical schoolNew York College of Osteo Medicine of New York Institute of Technology
Graduation year2004
Medicare specialtyEndocrinology
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$1,444 · 56 payments from 18 companies
  • 2024$1,224 · 76 payments from 21 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$235.9910
Sanofi-Aventis U.S. LLC$213.418
Amgen Inc.$200.804
Madrigal Pharmaceuticals$114.443
Mannkind Corporation$109.565

What the 2025 payments were for

  • Food and Beverage$1,444 · 56 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Bayside

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New York →